Summary Of: Antiretroviral drug

Encyclodia Page On: Antiretroviral drug

These Are Links To Other Documents

Spicerhaart | retroviruses | HIV | National Institutes of Health | AIDS | viral resistance | Nucleoside & nucleotide reverse transcriptase inhibitors (NRTI) | Non-nucleoside reverse transcriptase inhibitors (nNRTI) | Protease inhibitors | protease | proteins | virons | Integrase inhibitors | integrase | integration | raltegravir | Entry inhibitors | Maraviroc | enfuvirtide | Maturation inhibitors | gag | bevirimat | Vivecon | v | d | Antivirals | HIV | HAART | J05 | Nucleoside & Nucleotide Reverse Transcriptase Inhibitors (NRTI) | Abacavir (ABC) | Emtricitabine (FTC) | KP-1461 | Lamivudine (3TC) | Tenofovir | Didanosine (ddI) | Zidovudine (AZT) | Apricitabine | Stampidine | Elvucitabine | Racivir | Amdoxovir | Stavudine (d4T) | Zalcitabine (ddC) | Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTI) | Efavirenz | Nevirapine | Etravirine | Rilpivirine | Loviride | Delavirdine | Protease Inhibitors (PI) | Atazanavir | Brecanavir | Fosamprenavir | Lopinavir | Darunavir | Nelfinavir | Ritonavir | Saquinavir | Tipranavir | Amprenavir | Indinavir | Entry/fusion inhibitors | Aplaviroc | Enfuvirtide | Maraviroc | Vicriviroc | PRO 140 | Ibalizumab | Integrase inhibitors | Raltegravir | Elvitegravir | Maturation inhibitors | Bevirimat | Vivecon | Combined formulations | Combivir | Atripla | Trizivir | Truvada | Kaletra | Epzicom | Abzyme | Calanolide A | Ceragenin | Cyanovirin-N | Diarylpyrimidines | Epigallocatechin gallate (EGCG) | Foscarnet | Globoidnan A | Griffithsin | Hydroxyurea | Miltefosine | Portmanteau inhibitors | Seliciclib | Synergistic enhancers | Tre recombinase | Zinc finger protein transcription factor | DHHS | first-line agent | clinical trials | FDA | Development | Fixed dose combinations | Synergistic enhancers | ritonavir | protease inhibitors | Kaletra | lopinavir | v/v | protease inhibitors | saquinavir | atazanavir | integrase inhibitor | | citations | verification | reliable references | challenged | life cycle of HIV | enzymes | RNA | DNA | reverse transcription | mutations | virus | natural selection | synergies | fixed dose combinations | World Health Organization | United States Department of Health and Human Services | efavirenz | zidovudine | lamivudine | tenofovir | emtricitabine | lopinavir | ritonavir | stavudine | nevirapine | | cite | references or sources | reliable sources | Unverifiable | HIV | diabetes | blood pressure | CD4 | AIDS | viral load | thymus | hepatitis C | | cite | references or sources | reliable sources | Unverifiable | HIV | Drug holidays | thymus | immune reconstitution inflammatory syndrome | Abdominal pain | Alopecia | Anemia | Asthenia | Diarrhea | Dizziness | Fanconi syndrome | Flatulence | Headache | Hepatitis | Hyperbilirubinemia | Hypercholesterolemia | Hyperpigmentation | Ingrown nails | Insomnia | Jaundice | Lipodystrophy | Liver failure | Malaise | Mental confusion | Mitochondrial toxicity | Myalgia | Myalgic Encephalomyelitis | Myopathy | Nausea | Neutropenia | Nightmares | ulcers | Pancreatitis | Paresthesia | Peripheral neuropathy | Rash | Renal failure | Somnolence | Stevens-Johnson syndrome | taste | Vomiting | Xeroderma | Xerostomia | Antiviral drug | 2007 | 08-28 | doi | United States Department of Health and Human Services | 2006 | 07-03 | World Health Organization | 2006 | 01-17 | October 6 | 2005 | Department of Health and Human Services | 2006 | 01-17 | Department of Health and Human Services | 2006 | 11-04 | doi | November 3 | 2005 | Department of Health and Human Services | 2006 | 01-17 | doi | doi | 2006 | 01-07 | v | d | HIV | AIDS | HIV | HIV structure and genome | Safe sex | HIV test | CDC Classification System for HIV Infection | HIV disease progression rates | HIV vaccine | WHO Disease Staging System for HIV Infection and Disease | AIDS dementia complex | Tuberculosis coinfection | AIDS origin | AIDS pandemic | AIDS Museum | AIDS timeline | International AIDS Conference | International AIDS Society | World AIDS Day | Treatment Action Campaign | Joint United Nations Programme on HIV/AIDS (UNAIDS) | President's Emergency Plan for AIDS Relief (PEPFAR) | NAMES Project AIDS Memorial Quilt | HIV and AIDS misconceptions | List of HIV-positive people | People With AIDS Self-Empowerment Movement | HIV–positive fictional characters | AIDS advocacy | Denialism | Duesberg hypothesis | Group for the Scientific Reappraisal of the HIV-AIDS Hypothesis | AIDS pandemic | Africa | South Africa | Uganda | United States | Asia | China (PRC) | India | Japan | Myanmar (Burma) | Pakistan | Taiwan (ROC) | Caribbean | Eastern Europe Central Asia | Russia | Western Europe | Latin America | Brazil | List of countries by HIV/AIDS adult prevalence rate | v | d | Antivirals | HIV | J05 | S01AD | D06BB | herpesvirus | DNA | I | purine analogue | guanine | Aciclovir | Famciclovir | Ganciclovir | Penciclovir | Valaciclovir | Valganciclovir | Vidarabine | pyrimidine analogue | uridine | Idoxuridine | Trifluridine | Brivudine | Cidofovir | Docosanol | Fomivirsen | Foscarnet | Tromantadine | HPV | MC | Imiquimod | Podophyllotoxin | Hepatitis B | Adefovir | Clevudine | Interferon alfa-2b | Pegylated interferon alfa-2a | Entecavir | Lamivudine | Telbivudine | Tenofovir | Hepatitis C | RNA | IV | Pegylated interferon alpha | Ribavirin | Taribavirin | Boceprevir | Telaprevir | Picornavirus | Pleconaril | influenza | Arbidol | adamantane derivatives | M2 inhibitors | Amantadine | Rimantadine | neuraminidase inhibitors | Oseltamivir | Zanamivir | Peramivir | HIV | Reverse | HIV pharm | Inosine | Interferon | clinical trials | FDA | Categories | Antiretroviral drugs | Articles needing additional references from August 2007 | Articles lacking sources from June 2007 | All articles lacking sources |